CathWorks

CathWorks is a medical device company specializing in AI-driven interventional cardiology software and systems. The company's flagship product is the FFRangio® System, a non-invasive physiologic assessment platform used in cardiac catheterization laboratories. The FFRangio System combines artificial intelligence and advanced computational science to derive fractional flow reserve (FFR) measurements directly from routine angiographic images, eliminating the need for invasive pressure wires and drug stimulation (adenosine). The system provides real-time physiologic data at multiple points along the coronary tree, enabling interventional cardiologists to assess lesion severity and ischemia non-invasively during coronary angiography procedures. Key features include simulated pullback curves for functional CAD pattern differentiation, Lesion Impact analysis for residual ischemia assessment post-intervention, and integrated sizing tools for non-invasive lesion measurements. The CathWorks FFRangio System is deployed across major U.S. health systems including Northwell Health, Hackensack Meridian Health, Lehigh Valley Health Network, and AdventHealth, with documented adoption milestones such as Lenox Hill Hospital reaching 1,000 cases. The technology is positioned for interventional cardiologists and interventional radiologists performing coronary angiography and percutaneous coronary intervention (PCI) procedures. The company emphasizes workflow efficiency, procedural planning optimization, and improved clinical decision-making through comprehensive hemodynamic and morphologic data integration.